MedMine
MedMine sees purchase orders from over 2,000 hospitals, surgical centers and other medical facilities in the US. This equates to over 2mill transactions on a monthly basis. We then standardize, map and transform the data. Our three product offerings include 1.) A library of syndicated models (that get as granular as product level purchases), 2.) A data feed showing company level sales for over 100 equity securities, 3.) Bespoke research projects utilizing the vast amounts of information in our database.
Other
main data source2013
Year Company Founded1 - 10
Discretionary Asset Manager Customers10
A ABAX ABBV ABC ABMD ABT AGN AKRX ALOG ALR ALXN AMAG AMGN AMPH ANGO APEN ARAY ATRC ATRS AVGR AVNS AXGN BABY BAX BCR BDX BEC BHC BIO BMET BMY BSX CAH CARA CASM CELG CERN CFMS CNMD COV CRL CRY CSII CTEC.L CYBX CYNO DGX DHR DXCM ELGX EW FMS GILD GKOS GMED GNMK GZBX HAE HNGR HOLX HRC HSIC HYH IART ICUI IDXX ILMN INSP ISRG IVC JNJ KIDS KMB KTWO LIVN LLY LMAT LMNX LNTH MASI MCK MDRX MDT MDXG MMSI MNK MRK MTD MYL MZOR NEOG NKTR NUVA NXTM OCUL OFIX OMI OSIR OSUR PDCO PEN PFE PKI PRGO QDEL QGEN REGN RMD RMTI RTIX RVP SIBN SIEN SNN SNY SONVF SPNC SPPI SRN STE STJ SYK TECH TFX TMO TRNX UTMD VAR VIVO VREX VRX WAT WMGI XENT XRAY ZBH ZMH
Medical Device & Hospital Supply
n/a
Hedge Fund
Healthcare
401 Park Avenue South, Ste 10-025, NY 10016
Platform Based,
>$10K / mo
We offer 3 products - 1. A library of syndicated models. Access to all models - $100k/yr, Access to 5 tickers (which can be swapped every 6 months) - $50k/yr, Access to 1 ticker (which can be swapped every 6 months) - $15k/yr. 2. Data feed of 1300 manufacturers mapped to over 100 equity securities. 3. Bespoke research projects utilizing our vast database
2009
US
Valuable insights on hundreds of medical device companies
Proprietary data standardization algorithm and software provides a competitive advantage. Our database has a much longer history than our competitors.
-Revenue forecasting (the majority of our models were within 2% of reported quarterly sales for the specific companies in 2017) -Mix, Volume & Price analysis -Benchmarking -New product adoption rates -Sales comparisons of competing products